I just posted the last part of my ASH 2012 interview with Dr. Pagel on my blog: bkoffman.blogspot.com
This short segment focuses only on transplant. Dr. Pagel discusses the use of a very underutilized treatment option, namely radioimmunotherapies such Zevalin and the improving survival data. If there is no relapse after three years, the chances of the cancer coming back are very very small. We are talking cure.